Cargando…

Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine

Classical hairy cell leukemia (cHCL) and related mature lymphoid B-cell neoplasms including hairy cell leukemia variant (HCLv) and splenic diffuse red pulp lymphoma (SDRPL) are a rare subset of lymphoid neoplasms. cHCL accounts for around 2% of all leukemias and is characterized by a peripheral smea...

Descripción completa

Detalles Bibliográficos
Autores principales: Otieno, Steve B, Ogbeide, Osarenren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188828/
https://www.ncbi.nlm.nih.gov/pubmed/35698717
http://dx.doi.org/10.7759/cureus.24976
_version_ 1784725461645918208
author Otieno, Steve B
Ogbeide, Osarenren
author_facet Otieno, Steve B
Ogbeide, Osarenren
author_sort Otieno, Steve B
collection PubMed
description Classical hairy cell leukemia (cHCL) and related mature lymphoid B-cell neoplasms including hairy cell leukemia variant (HCLv) and splenic diffuse red pulp lymphoma (SDRPL) are a rare subset of lymphoid neoplasms. cHCL accounts for around 2% of all leukemias and is characterized by a peripheral smear with large lymphoid cells with cytoplasmic projections giving the cells a hairy appearance, splenomegaly, and cytopenias. Majority of cHCL cases harbor a BRAFV600E mutation. cHCL usually responds well to single-agent purine analogs. HCLv is even rarer and constitutes around 0.4% of lymphoid malignancies. Unlike cHCL, HCLv is less responsive to standard single-agent purine analogs and typically does not harbor the BRAFV600E mutation. The “hairy cells,” splenomegaly, and cytopenias are common in both. We report a case of a patient with HCLv who was treated with a single purine analog and achieved a near-complete response.
format Online
Article
Text
id pubmed-9188828
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-91888282022-06-12 Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine Otieno, Steve B Ogbeide, Osarenren Cureus Oncology Classical hairy cell leukemia (cHCL) and related mature lymphoid B-cell neoplasms including hairy cell leukemia variant (HCLv) and splenic diffuse red pulp lymphoma (SDRPL) are a rare subset of lymphoid neoplasms. cHCL accounts for around 2% of all leukemias and is characterized by a peripheral smear with large lymphoid cells with cytoplasmic projections giving the cells a hairy appearance, splenomegaly, and cytopenias. Majority of cHCL cases harbor a BRAFV600E mutation. cHCL usually responds well to single-agent purine analogs. HCLv is even rarer and constitutes around 0.4% of lymphoid malignancies. Unlike cHCL, HCLv is less responsive to standard single-agent purine analogs and typically does not harbor the BRAFV600E mutation. The “hairy cells,” splenomegaly, and cytopenias are common in both. We report a case of a patient with HCLv who was treated with a single purine analog and achieved a near-complete response. Cureus 2022-05-13 /pmc/articles/PMC9188828/ /pubmed/35698717 http://dx.doi.org/10.7759/cureus.24976 Text en Copyright © 2022, Otieno et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Otieno, Steve B
Ogbeide, Osarenren
Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
title Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
title_full Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
title_fullStr Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
title_full_unstemmed Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
title_short Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
title_sort remarkable response of hairy cell leukemia variant to single-agent cladribine
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188828/
https://www.ncbi.nlm.nih.gov/pubmed/35698717
http://dx.doi.org/10.7759/cureus.24976
work_keys_str_mv AT otienosteveb remarkableresponseofhairycellleukemiavarianttosingleagentcladribine
AT ogbeideosarenren remarkableresponseofhairycellleukemiavarianttosingleagentcladribine